US 10472412
Bispecific multivalent fusion proteins
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 10472412 (Bispecific multivalent fusion proteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P31/18